K. H. S. S. Al-din, “Metformin Reduces Inflammatory Markers Through AMPK Activation in Type 2 Diabetes Patients”, acopen, vol. 10, no. 2, p. 10.21070/acopen.10.2025.13015, Dec. 2025.